Luo Jun, Zhu Mingxuan, Zhao Long, He Meiwen, Li Bei, Liu Yifan, Sun Yuhan, Lyu Guoqing, Shen Zhanlong
Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen 518036, China.
Department of Gastroenterological Surgery, Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Peking University People's Hospital, Beijing 100044, China.
Chin J Cancer Res. 2024 Apr 30;36(2):226-232. doi: 10.21147/j.issn.1000-9604.2024.02.09.
Colorectal cancer has a high incidence and mortality rate in China, with the majority of cases being middle and low rectal cancer. Surgical intervention is currently the main treatment modality for locally advanced rectal cancer, with the common goal of improving oncological outcomes while preserving function. The controversy regarding the circumferential resection margin distance in rectal cancer surgery has been resolved. With the promotion of neoadjuvant therapy concepts and advancements in technology, treatment strategies have become more diverse. Following tumor downstaging, there is an increasing trend towards extending the safe distance of distal rectal margin. This provides more opportunities for patients with low rectal cancer to preserve their anal function. However, there is currently no consensus on the specific distance of distal resection margin.
在中国,结直肠癌的发病率和死亡率都很高,大多数病例为中低位直肠癌。手术干预目前是局部晚期直肠癌的主要治疗方式,其共同目标是在保留功能的同时改善肿瘤学结局。直肠癌手术中切缘距离的争议已经得到解决。随着新辅助治疗理念的推广和技术进步,治疗策略变得更加多样化。在肿瘤降期后,远端切缘安全距离有延长的趋势。这为低位直肠癌患者保留肛门功能提供了更多机会。然而,目前对于远端切缘的具体距离尚无共识。